Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
Irina Kusmartseva(University of Florida), Mark A. Atkinson(University of Florida), Xiao‐Han Tang(Tianjin University of Science and Technology), Amanda L. Posgai(University of Florida), Jack L. Harbert(Louisiana State University), Paul Joseph(University of Florida), Alberto Pugliese(University of Miami), Changjun Yang(Allen Institute for Brain Science), Marda Jorgensen(University of Florida), Farooq Syed(Indiana University – Purdue University Indianapolis), Richard S. Vander Heide(Louisiana State University Health Sciences Center New Orleans), Harry S. Nick(University of Florida), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), Eduardo Candelario‐Jalil(University of Florida), Sirlene Cechin(University of Miami), John Paulsen(Icahn School of Medicine at Mount Sinai), Wenting Wu(Indiana University School of Medicine), Martha Campbell‐Thompson(University of Florida), Dirk Homann(Miami Transplant Institute), Richard E. Lloyd(Baylor College of Medicine), Verena van der Heide(Icahn School of Medicine at Mount Sinai)
Cited by 179
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k